Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive Disorder
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Young-Min | - |
dc.contributor.author | Lee, Heon-Jeong | - |
dc.contributor.author | Kang, Seung-Gul | - |
dc.contributor.author | Cho, Jae-Hyuck | - |
dc.contributor.author | Kim, Leen | - |
dc.date.accessioned | 2021-09-08T11:01:34Z | - |
dc.date.available | 2021-09-08T11:01:34Z | - |
dc.date.created | 2021-06-11 | - |
dc.date.issued | 2009-12 | - |
dc.identifier.issn | 1738-3684 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/118813 | - |
dc.description.abstract | Bupropion is a selective norepinephrine and dopamine reuptake inhibitor with no serotonergic activity, and is therefore an antidepressant with unique pharmacological properties. There are some reports that selective serotonin reuptake inhibitors (SSRIs) or mirtazapine can induce adverse effects including restless legs syndrome (RLS) and that bupropion can reverse these adverse effects. Here, we report about a patient with a major depressive disorder who exhibited RLS after being treated with pregabalin and mirtazapine. This adverse effect disappeared after having switched from mirtazapine to bupropion. Bupropion inhibits the reuptake of dopamine and increases dopamine neurotransmission in both the nucleus accumbens and the prefrontal cortex. This pharmacological profile can be effective in patients with RLS related to dopamine hypoactivity. However, the limitations of this single case report mean that further investigations with larger samples are needed. Psychiatry Invest 2009;6:313-315 | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN NEUROPSYCHIATRIC ASSOC | - |
dc.subject | GLUTAMATE RELEASE | - |
dc.subject | NEUROPATHIC PAIN | - |
dc.subject | GABAPENTIN | - |
dc.subject | INHIBITION | - |
dc.subject | CRITERIA | - |
dc.subject | SLICES | - |
dc.title | Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive Disorder | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Heon-Jeong | - |
dc.contributor.affiliatedAuthor | Kim, Leen | - |
dc.identifier.doi | 10.4306/pi.2009.6.4.313 | - |
dc.identifier.scopusid | 2-s2.0-75649127611 | - |
dc.identifier.wosid | 000273127800012 | - |
dc.identifier.bibliographicCitation | PSYCHIATRY INVESTIGATION, v.6, no.4, pp.313 - 315 | - |
dc.relation.isPartOf | PSYCHIATRY INVESTIGATION | - |
dc.citation.title | PSYCHIATRY INVESTIGATION | - |
dc.citation.volume | 6 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 313 | - |
dc.citation.endPage | 315 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001430979 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | GLUTAMATE RELEASE | - |
dc.subject.keywordPlus | NEUROPATHIC PAIN | - |
dc.subject.keywordPlus | GABAPENTIN | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | CRITERIA | - |
dc.subject.keywordPlus | SLICES | - |
dc.subject.keywordAuthor | Restless legs syndrome | - |
dc.subject.keywordAuthor | Bupropion | - |
dc.subject.keywordAuthor | Pregabalin | - |
dc.subject.keywordAuthor | Mirtazapine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.